Slørdal L, Warren D J, Moore M A
Laboratory of Developmental Hematopoiesis, Memorial Sloan-Kettering Cancer Center, New York 10021.
J Immunol. 1989 Feb 1;142(3):833-5.
Intravenous bolus administration of a single 2-micrograms dose of murine rTNF-alpha to BALB/c mice 20 h before sublethal total-body irradiation (7.5 Gy) conferred significant protection against radiation-induced leukopenia. Murine rTNF-alpha administration not only reduced the decline of neutrophil and total blood cell counts after radiation, but also accelerated the subsequent normalization of peripheral blood cell counts. This was accompanied by accelerated regeneration of primitive hematopoietic progenitors, as determined by the in vivo spleen CFU assay, and the in vitro assay of the more mature hematopoietic cell compartment. This demonstrates that pretreatment with murine rTNF-alpha enhances hematopoietic reconstitution after sublethal irradiation, and indicates a possible therapeutic potential for this agent in the treatment of radiation-induced myelo-suppression.
在亚致死性全身照射(7.5 Gy)前20小时,给BALB/c小鼠静脉推注单剂量2微克的鼠源重组肿瘤坏死因子-α(murine rTNF-alpha),可显著保护小鼠免受辐射诱导的白细胞减少症。给予鼠源重组肿瘤坏死因子-α不仅减少了辐射后中性粒细胞和全血细胞计数的下降,还加速了外周血细胞计数随后的恢复正常。这伴随着原始造血祖细胞的加速再生,这通过体内脾脏集落形成单位(CFU)测定以及更成熟造血细胞区室的体外测定得以确定。这表明用鼠源重组肿瘤坏死因子-α预处理可增强亚致死性照射后的造血重建,并表明该药物在治疗辐射诱导的骨髓抑制方面可能具有治疗潜力。